atai Life Sciences (ATAI) Competitors $5.96 -0.04 (-0.67%) Closing price 10/15/2025 04:00 PM EasternExtended Trading$5.97 +0.01 (+0.17%) As of 10/15/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ATAI vs. ARWR, PTGX, ACLX, AKRO, KYMR, MENS, CRNX, NAMS, VKTX, and LNTHShould you be buying atai Life Sciences stock or one of its competitors? The main competitors of atai Life Sciences include Arrowhead Pharmaceuticals (ARWR), Protagonist Therapeutics (PTGX), Arcellx (ACLX), Akero Therapeutics (AKRO), Kymera Therapeutics (KYMR), Jyong Biotech (MENS), Crinetics Pharmaceuticals (CRNX), NewAmsterdam Pharma (NAMS), Viking Therapeutics (VKTX), and Lantheus (LNTH). These companies are all part of the "pharmaceutical products" industry. atai Life Sciences vs. Its Competitors Arrowhead Pharmaceuticals Protagonist Therapeutics Arcellx Akero Therapeutics Kymera Therapeutics Jyong Biotech Crinetics Pharmaceuticals NewAmsterdam Pharma Viking Therapeutics Lantheus atai Life Sciences (NASDAQ:ATAI) and Arrowhead Pharmaceuticals (NASDAQ:ARWR) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, risk, dividends and analyst recommendations. Do insiders and institutionals hold more shares of ATAI or ARWR? 28.4% of atai Life Sciences shares are held by institutional investors. Comparatively, 62.6% of Arrowhead Pharmaceuticals shares are held by institutional investors. 26.8% of atai Life Sciences shares are held by insiders. Comparatively, 4.3% of Arrowhead Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Is ATAI or ARWR more profitable? Arrowhead Pharmaceuticals' return on equity of -40.91% beat atai Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets atai Life SciencesN/A -85.43% -64.38% Arrowhead Pharmaceuticals N/A -40.91%-11.62% Do analysts prefer ATAI or ARWR? atai Life Sciences currently has a consensus target price of $11.40, suggesting a potential upside of 91.28%. Arrowhead Pharmaceuticals has a consensus target price of $43.14, suggesting a potential upside of 12.97%. Given atai Life Sciences' stronger consensus rating and higher probable upside, equities analysts clearly believe atai Life Sciences is more favorable than Arrowhead Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score atai Life Sciences 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 2.88Arrowhead Pharmaceuticals 1 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 2.78 Which has more risk and volatility, ATAI or ARWR? atai Life Sciences has a beta of 1.58, indicating that its share price is 58% more volatile than the S&P 500. Comparatively, Arrowhead Pharmaceuticals has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500. Which has higher valuation and earnings, ATAI or ARWR? atai Life Sciences has higher earnings, but lower revenue than Arrowhead Pharmaceuticals. Arrowhead Pharmaceuticals is trading at a lower price-to-earnings ratio than atai Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratioatai Life Sciences$310K4,494.61-$149.27M-$0.69-8.64Arrowhead Pharmaceuticals$3.55M1,487.37-$599.49M-$1.28-29.84 Does the media refer more to ATAI or ARWR? In the previous week, Arrowhead Pharmaceuticals had 5 more articles in the media than atai Life Sciences. MarketBeat recorded 10 mentions for Arrowhead Pharmaceuticals and 5 mentions for atai Life Sciences. Arrowhead Pharmaceuticals' average media sentiment score of 0.79 beat atai Life Sciences' score of 0.58 indicating that Arrowhead Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment atai Life Sciences 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Arrowhead Pharmaceuticals 5 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Summaryatai Life Sciences beats Arrowhead Pharmaceuticals on 8 of the 14 factors compared between the two stocks. Get atai Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATAI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ATAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ATAI vs. The Competition Export to ExcelMetricatai Life SciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.40B$4.22B$6.11B$10.46BDividend YieldN/A1.25%5.73%4.77%P/E Ratio-8.6427.9885.3627.36Price / Sales4,494.61265.91602.77132.73Price / CashN/A27.8637.4661.86Price / Book8.644.7112.426.81Net Income-$149.27M$197.51M$3.32B$276.80M7 Day Performance9.36%1.73%0.57%0.42%1 Month Performance28.17%5.21%10.52%7.86%1 Year Performance392.56%25.67%72.99%41.24% atai Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ATAIatai Life Sciences3.1471 of 5 stars$5.96-0.7%$11.40+91.3%+446.8%$1.40B$310K-8.6480Analyst ForecastGap UpARWRArrowhead Pharmaceuticals3.8543 of 5 stars$36.25+2.4%$43.14+19.0%+92.1%$5.01B$3.55M-28.32400PTGXProtagonist Therapeutics1.702 of 5 stars$79.17-9.0%$72.00-9.1%+63.1%$4.93B$209.18M113.10120Analyst ForecastInsider TradeGap DownHigh Trading VolumeACLXArcellx1.9726 of 5 stars$86.23-0.7%$112.69+30.7%+2.7%$4.78B$107.94M-25.2180Analyst RevisionAKROAkero Therapeutics3.6808 of 5 stars$53.66-0.4%$73.38+36.7%+79.1%$4.29BN/A-26.8330Insider TradeHigh Trading VolumeKYMRKymera Therapeutics1.357 of 5 stars$59.89+4.7%$61.26+2.3%+40.4%$4.28B$44.71M-17.26170Insider TradeMENSJyong BiotechN/A$55.70+0.8%N/AN/A$4.23BN/A0.0031CRNXCrinetics Pharmaceuticals3.738 of 5 stars$44.43-1.1%$74.45+67.6%-23.4%$4.18B$1.39M-10.81210NAMSNewAmsterdam Pharma1.5618 of 5 stars$37.15+0.3%$42.00+13.1%+112.9%$4.18B$45.56M-22.934High Trading VolumeVKTXViking Therapeutics3.9803 of 5 stars$33.91+1.0%$86.42+154.8%-46.3%$3.81BN/A-22.1620Upcoming EarningsLNTHLantheus4.562 of 5 stars$54.59+2.0%$74.50+36.5%-49.5%$3.71B$1.53B14.52700Trending NewsAnalyst Revision Related Companies and Tools Related Companies ARWR Competitors PTGX Competitors ACLX Competitors AKRO Competitors KYMR Competitors MENS Competitors CRNX Competitors NAMS Competitors VKTX Competitors LNTH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ATAI) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding atai Life Sciences N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share atai Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
